FSGS and Kidney Transplant Outcome
Some FSGS patients can get complete clinical remission spontaneously, but most patients will finally have complete renal failure if untreated effectively. Then, kidney transplant may be used to extend patients' life expectancy, so kidney transplant outcome becomes FSGS patients' big concern.
FSGS is one kidney disease related to immune disorder, so there are some types of immune complexes such as IgM and C3 depositing in the affected glomeruli. When kidney function level is less than 15%, kidney transplant becomes one treatment option. However, the high recurrence rate of FSGS in transplanted kidney reduces transplant outcome.
It is reported that the risk of FSGS recurring in the transplanted kidney ranges from 20% to 50%. If the new kidney fails again, patients may need to return to dialysis or accept another kidney transplantation. This may frustrate kidney failure patients whose kidney disease is caused by FSGS.
In fact, there are several factors that can affect the recurrence chance of FSGS. For example:
- Patients are younger than 15 years old
- It takes less than 3 years that FSGS found in primary kidneys progresses into kidney failure
- Patients are white race
- Certain cells on patients' original kidney biopsy
Most often, a recurrence of FSGS in transplanted kidney happens within hours to days. Then, transplanted kidney loses its ability to work gradually.
Now, we can know the kidney transplant outcome isn't as good as we expect. Therefore, patients should take prompt treatments to prevent kidney failure as long as they are diagnosed with FSGS kidney disease. The longer they can live with their own kidneys, the better their prognosis.
Until now, several therapies such as Immunotherapy and Clear Blood Pollution Therapy have been created to treat FSGS. Consult the doctor online to learn how these therapies help FSGS to prevent kidney transplant.
Tag: FSGS FSGS Treatment
